Aspo Plc
3.3.2026 13:00:00 CET | Globenewswire | Press release
Aspo Plc - Managers' Transactions - Erkka Repo
Aspo Plc - Managers' Transactions - Erkka Repo
Aspo Plc Managers’ transactions March 3, 2026 at 14.00 EET
Aspo Plc - Managers' Transactions - Erkka Repo
____________________________________________
Person subject to the notification requirement
Name: Erkka Repo
Position: Chief Financial Officer
Issuer: Aspo Oyj
LEI: 7437000TB0GHDHLPX677
Notification type: INITIAL NOTIFICATION
Reference number: 145229/4/4
____________________________________________
Transaction date: 2026-03-02
Outside a trading venue
Instrument type: SHARE
ISIN: FI0009008072
Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE
Transaction details
(1): Volume: 5000 Unit price: 0 EUR
(2): Volume: 3682 Unit price: 0 EUR
Aggregated transactions (2):
Volume: 8682 Volume weighted average price: 0 EUR
Aspo Plc
Rolf Jansson
CEO
Distribution:
Nasdaq Helsinki
www.aspo.com
For more information, please contact: Rolf Jansson, CEO, Aspo Plc, tel. +358 400 600 264, rolf.jansson@aspo.com
Aspo creates value by owning and developing business operations sustainably and in the long term. Aspo’s businesses ESL Shipping and Telko enable future-proof, sustainable choices for customers in various industries. Established in 1929, today we are together about 650 experts on land and at sea. While the Nordic region is our core market, we serve our customers with world-class solutions in 18 countries around Europe and parts of Asia.
Aspo is listed on Nasdaq Helsinki and is headquartered in Finland.
Aspo – Sustainable value creation
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Kyowa Kirin3.3.2026 14:00:00 CET | Press release
Kyowa Kirin Announces Discontinuation of Rocatinlimab Clinical Trials
T-knife Therapeutics3.3.2026 14:00:00 CET | Press release
T-knife Therapeutics Announces Authorization of Clinical Trial Application for TK-6302, A Multi-Armored, CRISPR based T cell Therapy for Solid Tumors
ZenaTech Inc.3.3.2026 13:30:00 CET | Press release
ZenaTech’s ZenaDrone Advances U.S. Defense and Congressional Engagement with Blue UAS-Aligned Drone Development
Synchronoss Technologies, Inc.3.3.2026 13:30:00 CET | Press release
Jelly Toast Launches in India to Simplify Everyday Celebrations
Brookfield Asset Management Ltd3.3.2026 13:00:00 CET | Press release
BCI, Norges Bank Investment Management and Brookfield Partner to Launch Northview Energy
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom